Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01653834 · ClinicalTrials.gov registry record · NA
Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas
A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01653834 is a NA study that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 10 participants.
The verdict
NCT01653834, a NA study, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This research study is being done to see if lymphocytes can be collected from patients with high grade gliomas before they start standard radiation and chemotherapy. (Lymphocytes are cells that normally circulate in the blood and are an essential part of the immune system). The investigators goal is to store these and give them back to the patient after radiation is completed. This is part of a larger effort that will attempt to preserve the immune system from the effects of radiation and chemotherapy.
Interventions
- PROCEDURE Lymphocyte harvesting & reinfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01653834
The ClinicalTrials.gov registry entry for NCT01653834 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lymphocyte harvesting & reinfusion is the first listed.
NCT01653834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01653834 about?
NCT01653834 is a clinical study titled "Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas". This research study is being done to see if lymphocytes can be collected from patients with high grade gliomas before they start standard radiation and chemotherapy. (Lymphocytes are cells that normally circulate in the blood and are an essential part of the immune system). The investigators goal is...
What is the current status of trial NCT01653834?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2012-07. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01653834?
The interventions under investigation include: Lymphocyte harvesting & reinfusion (PROCEDURE).
Who is sponsoring clinical trial NCT01653834?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.